FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

E Gershonov

Research Profile

Living Beings

Disorders

Diabetes Mellitus, Experimental

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Antibody Formation

Phenomena

Magnetic Resonance Spectroscopy

Co-author Network

Publications

TOP 3
I Goldwaser; S Qian; E Gershonov; Mati Fridkin; Yoram Shechter
Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: establishing criteria for optimal chelators.
Q Sun; N Sekar; I Goldwaser; E Gershonov; Mati Fridkin; Yoram Shechter
Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism.
E Gershonov; I Goldwaser; Mati Fridkin; Yoram Shechter
A novel approach for a water-soluble long-acting insulin prodrug: design, preparation, and analysis of [(2-sulfo)-9-fluorenylmethoxycarbonyl](3)-insulin.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of E Gershonov (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: I Goldwaser; S Qian; E Gershonov; Mati Fridkin; Yoram Shechter
Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: establishing criteria for optimal chelators.
Molecular pharmacology 2000;58(4):738-46.
2000: Q Sun; N Sekar; I Goldwaser; E Gershonov; Mati Fridkin; Yoram Shechter
Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism.
American journal of physiology. Endocrinology and metabolism 2000;279(2):E403-10.
2000: E Gershonov; I Goldwaser; Mati Fridkin; Yoram Shechter
A novel approach for a water-soluble long-acting insulin prodrug: design, preparation, and analysis of [(2-sulfo)-9-fluorenylmethoxycarbonyl](3)-insulin.
Journal of medicinal chemistry 2000;43(13):2530-7.
2000: I Goldwaser; D Gefel; E Gershonov; Mati Fridkin; Yoram Shechter
Insulin-like effects of vanadium: basic and clinical implications.
Journal of inorganic biochemistry 2000;80(1-2):21-5.
1999: I Goldwaser; J Li; E Gershonov; Michal Armoni; Eddy Karnieli; Mati Fridkin; Yoram Shechter
L-Glutamic acid gamma-monohydroxamate. A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo.
The Journal of biological chemistry 1999;274(37):26617-24.
1999: E Gershonov; Yoram Shechter; Mati Fridkin
New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin.
Diabetes 1999;48(7):1437-42.
1996: E Gershonov; R Granoth; Esther Tzehoval; Y Gaoni; Mati Fridkin
1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs.
Journal of medicinal chemistry 1996;39(24):4833-43.
1994: N Greenspoon; Rami Hershkoviz; Ronen Alon; E Gershonov; B Lavie; Ofer Lider
Novel psi-S-CH2 peptide-bond replacement and its utilization in the synthesis of nonpeptidic surrogates of the Leu-Asp-Val sequence that exhibit specific inhibitory activities on CD4+ T cell binding to fibronectin.
International journal of peptide and protein research 1994;43(5):417-24.